Device Trial Radar · NCT04841304
Cardiac Arrhythmia in Patients With End-Stage Renal Disease
Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Jun 1, 2021
Primary completion
Apr 1, 2024
Study completion Mar 1, 2026
Sponsor
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Herlev Hospital; Steno Diabetes Center Copenhagen; University of Copenhagen; Hillerod Hospital, Denmark; Holbaek Sygehus
- First posted
- Apr 12, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will examine the presence of cardiac arrhythmias in patients receiving hemodialysis and the role of diabetes, hypoglycemia and parameters related to uremia and the dialysis procedure. The study is designed as a prospective cohort study with 18 months follow-up. 70 patients receiving chronic hemodialysis will be recruited and equipped with implantable loop recorders (ILR): 35 patients with diabetes and 35 patients without diabetes. Data collection during the follow-up includes continuous monitoring of the heart rhythm by the ILR for the entire follow-up period, continuous glucose monitoring for 10 days every second month, and monthly collection of blood samples and dialytic parameters. After the initial 18-month follow-up, heart rhythm monitoring will continue until the ILR battery runs out for those participants who wish to continue.
Conditions
- End Stage Renal Disease on Dialysis
- Cardiac Arrhythmia
- Diabetes Mellitus
- Hypoglycemia
Interventions
Loop recorder (Reveal LINQ, Medtronic)Device
Implantation of a loop-recorder
Continuous Glucose Measurement (G6, Dexcom)Device
Monitoring with a continuous glucose monitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinically significant arrhythmiasTime frame: 18 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Department of Nephrology, Rigshospitalet
Copenhagen, Denmark
Department of Nephrology, Herlev Hospital
Herlev, Denmark
Department of Nephrology, North Zealand Hospital
Hillerød, Denmark
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.